Delenex May Be First Therapeutic Company With Tissue Penetrant Antibodies
Delenex Therapeutics, a Swiss biotech in the Greater Zurich Area is developing antibodies to treat serious medical conditions with high unmet need.
Delenex Therapeutics, a Swiss biotech in the Greater Zurich Area is developing antibodies to treat serious medical conditions with high unmet need.
Copyright © 2024 | WordPress Theme by MH Themes